Ignite Creation Date:
2024-05-06 @ 7:26 AM
Last Modification Date:
2024-10-26 @ 11:48 AM
Study NCT ID:
NCT02530476
Status:
COMPLETED
Last Update Posted:
2020-03-31
First Post:
2015-08-19
Brief Title:
Phase III Study of Selective Inhibitor of Nuclear Export SINE Selinexor KPT-330 Sorafenib in Acute Myeloid Leukemia
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Organization Data
Organization:
MD Anderson Cancer Center
Class:
OTHER
Study ID:
2014-0975
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MD Anderson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Karyopharm Therapeutics Inc | INDUSTRY |
| National Cancer Institute NCI | NIH |